Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2497998 | 1.00 | TSHR (0.43) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL3985766 | 1.00 | TSHR (0.43) | TSHRLMNATHRBDNM1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8554606 | 0.96 | TSHR (0.40) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL6033 | 0.96 | TSHR (0.46) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL7874985 | 0.96 | TSHR (0.46) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL821221 | 0.96 | TSHR (0.46) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL15656735 | 0.92 | TSHR (0.43) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL11575346 | 0.92 | TSHR (0.43) | TSHRLMNATHRBDNM1ALDH1A1 | |
| Iodide SCHEMBL3974532 | 0.92 | TSHR (0.43) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL7631534 | 0.92 | TSHR (0.43) | TSHRLMNATHRBDNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0021769-B1 | PROCESSES FOR PRODUCING 2,6-DIMETHYL-3-ALKOXY-OCT-1-EN-8-OL, DEHYDROCITRONELLOL AND 2-(2'-METHYL-1'-PROPENYL)-4-METHYLTETRAHYDROPYRAN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-03-09 | — | — | EP | claimed |
| EP-0021769-A1 | Processes for producing 2,6-dimethyl-3-alkoxy-oct-1-en-8-ol, dehydrocitronellol and 2-(2'-methyl-1'-propenyl)-4-Methyltetrahydropyran | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-01-07 | — | — | EP | claimed |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12552813-B2 | Heterocyclic substituted pyrimidopyran compound and use thereof | MEDSHINE DISCOVERY INC. (CN) | 2026-02-17 | — | — | US | disclosed |
| EP-4680336-A1 | AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | Ventus Therapeutics U.S., Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20260007684-A1 | AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | VENTUS THERAPEUTICS U S INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250250288-A1 | HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUND AND USE THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2025-08-07 | — | — | US | disclosed |
| CN-120136882-A | Organic compound and application thereof | 清华大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-119855822-A | Heterocyclic substituted pyrimidopyran compounds and application thereof | 南京明德新药研发有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119054439-A | Organic light emitting device | 株式会社LG化学 | 2024-11-29 | — | — | CN | disclosed |
| CN-113316568-B | 2-Formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin | 全球血液疗法股份有限公司 | 2024-11-08 | — | — | CN | disclosed |
| EP-0784066-A1 | HYDROGENATED RING-OPENING POLYMER | NIPPON ZEON CO., LTD. (JP) | 1997-07-16 | — | — | EP | disclosed |
| US-5600034-A | HEAT TREATING DIALLYL ETHERS IN PRESENCE OF CATALYST CONTAINING PALLADIUM AND PHOSPHORUS COMPOUNDS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-02-04 | — | — | US | disclosed |
| US-5557016-A | HYDROXYLATION OF CONJUGATED ALKADIENES IN THE PRESENCE OF PALLADIUM CATALYSIS | MITSUBISHI KASEI CORPORATION (JP) | 1996-09-17 | — | — | US | disclosed |
| US-5481049-A | REACTING CONJUGATED DIENE AND WATER IN PRESENCE OF CARBON DIOXIDE, USING PALLADIUM COMPOUND AND A FREE PHOSPHINE AS CATALYSTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-01-02 | — | — | US | disclosed |
| EP-0605735-A1 | PROCESS FOR PRODUCING ALKADIENOL | Mitsubishi Chemical Corporation (JP) | 1994-07-13 | — | — | EP | disclosed |
| EP-0021769-B1 | PROCESSES FOR PRODUCING 2,6-DIMETHYL-3-ALKOXY-OCT-1-EN-8-OL, DEHYDROCITRONELLOL AND 2-(2'-METHYL-1'-PROPENYL)-4-METHYLTETRAHYDROPYRAN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-03-09 | — | — | EP | disclosed |
| US-4340544-A | FROM CITRONELLOC IN THE PRESENCE OF AN ALKALI METAL ARYL SULFONATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-07-20 | — | — | US | disclosed |
| US-4312717-A | ANODIC ALKOXYLATION OF CITRONELLOL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-01-26 | — | — | US | disclosed |
| EP-0021769-A1 | Processes for producing 2,6-dimethyl-3-alkoxy-oct-1-en-8-ol, dehydrocitronellol and 2-(2'-methyl-1'-propenyl)-4-Methyltetrahydropyran | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250288-A1 | HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUND AND USE THEREOF | TPMT, CYP2C9, PAH | TSHR 2610/4885LMNA 4811/4885THRB 3876/4885 |
| US-12552813-B2 | Heterocyclic substituted pyrimidopyran compound and use thereof | UROD, SLC6A7, SLC38A7 | TSHR 2657/4885LMNA 3549/4885THRB 2659/4885 |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | HBZ, HBB, HBG2 | TSHR 1596/4885LMNA 1281/4885THRB 1067/4885 |
| US-20260007684-A1 | AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | NOD1, NLRP3, NOD2 | TSHR 3171/4885LMNA 457/4885THRB 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.